Vanillic Acid
CAS 121-34-6
Vanillic Acid (CAS 121-34-6) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 68871.42857142857 nM | 14 | - |
| - | MIC | 3435500 nM | 6 | - |
| - | Potency | 29585.225000000002 nM | 4 | - |
| - | EC50 | 21085 nM | 2 | - |
| - | Kd | 250002 nM | 2 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Vanillic Acid used for in pharmaceutical contexts?
Vanillic Acid (CAS 121-34-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Vanillic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Vanillic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Vanillic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Vanillic Acid with EU status "permitted".
What clinical phase is Vanillic Acid in?
No phase 1-4 clinical development badge is rendered for Vanillic Acid because the matched compound identifier rows do not contain a max-phase value.